October 2016

Filling the Donut Hole in Oncology Care With Collaboration and Navigation

October 14, 2016

Evidence-Based Oncology

To discuss the progress in care collaboration and also what is currently lacking in care practices in oncology, The American Journal of Managed Care® invited Rebekkah Schear, MIA, LIVESTRONG Foundation, and Michael Kolodziej, MD, Flatiron Health.

Multi-Level Approach to Addressing Iatrogenic Infertility

October 17, 2016

Evidence-Based Oncology

A socioecological approach focused on patient care, education and resources for providers, and programs within cancer institutions will ensure that the risk of infertility, frequently associated with cancer treatment, will be addressed and routinely included as part of cancer care. This article discusses LIVESTRONG's efforts to achieve this goal.

Enhancing Healthcare Delivery Research at the National Cancer Institute

October 17, 2016

Evidence-Based Oncology

The National Cancer Institute's Division of Cancer Control and Population Sciences created the Healthcare Delivery Research Program in January 2015, recognizing the need for empirical evidence to address cancer care challenges.

Learning About Oncologist—Patient Communications by Speaking Directly With Each

October 18, 2016

Evidence-Based Oncology

The importance of doctor-patient communication is well established. Focus groups conducted with patients and oncologists help unravel why gaps exists and how to customize strategies for improvement.

Minding the Gaps and Filling the Chasms in Oncology

October 18, 2016

Evidence-Based Oncology

As we enter a time of extraordinary advances in cancer care, some of the optimism over these advances has been tem­pered by the growing realization of the challenges of delivering these cancer care solutions.

Obesity: A Growing Burden for Cancer Survivors

October 20, 2016

Evidence-Based Oncology

Patients with a history of cancer were more likely to suffer from obesity than the general population, according to new research studying the incidence of obesity in cancer survivors.

A New Biomarker Predicts Response to Pembrolizumab in Advanced Melanoma

October 20, 2016

Evidence-Based Oncology

A new study by researchers at the Perelman School of Medicine at the University of Pennsylvania has identified a biomarker that can predict response to treatment with pembrolizumab in stage IV patients with melanoma.